Page last updated: 2024-08-22

buthionine sulfoximine and Glioblastoma with Sarcomatous Component

buthionine sulfoximine has been researched along with Glioblastoma with Sarcomatous Component in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belcuig, M; Chopp, M; Grenier, J; Jiang, F; Li, Y; Lilge, L; Singh, G	1

Other Studies

1 other study(ies) available for buthionine sulfoximine and Glioblastoma with Sarcomatous Component

Article	Year
Photodynamic therapy using Photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain. Lasers in surgery and medicine, 1998, Volume: 23, Issue:3 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Chemistry; Brain Neoplasms; Buthionine Sulfoximine; Chromatography, High Pressure Liquid; Dihematoporphyrin Ether; Free Radicals; Gliosarcoma; Glutathione; Male; Necrosis; Oxidation-Reduction; Photochemotherapy; Radiation-Sensitizing Agents; Rats; Rats, Inbred F344; Reactive Oxygen Species	1998

Article

Year

Photodynamic therapy using Photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain.

Lasers in surgery and medicine, 1998, Volume: 23, Issue:3

Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Chemistry; Brain Neoplasms; Buthionine Sulfoximine; Chromatography, High Pressure Liquid; Dihematoporphyrin Ether; Free Radicals; Gliosarcoma; Glutathione; Male; Necrosis; Oxidation-Reduction; Photochemotherapy; Radiation-Sensitizing Agents; Rats; Rats, Inbred F344; Reactive Oxygen Species

1998